Literature DB >> 16932443

Can glomerulosclerosis be reversed?

Agnes B Fogo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16932443     DOI： 10.1038/ncpneph0200

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN： 1745-8323


× No keyword cloud information.
  6 in total

Review 1.  Modulation of glomerulosclerosis.

Authors:  Li-Jun Ma; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2007-09-08       Impact factor: 9.623

2.  Increased capillary branching contributes to angiotensin type 1 receptor blocker (ARB)-induced regression of sclerosis.

Authors:  Benjamin S Scruggs; Yiqin Zuo; Ellen Donnert; Lijun Ma; John F Bertram; Agnes B Fogo
Journal:  Am J Pathol       Date:  2011-03-03       Impact factor: 4.307

3.  The targeted podocyte.

Authors:  Agnes B Fogo
Journal:  J Clin Invest       Date:  2011-05-23       Impact factor: 14.808

4.  Renin-angiotensin axis blockade reduces proteinuria in presymptomatic patients with familial FSGS.

Authors:  Lawrence Copelovitch; Marta Guttenberg; Martin R Pollak; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2007-05-25       Impact factor: 3.714

5.  Animal models mimicking aminoglycoside-induced renal damage.

Authors:  Sandra Rodríguez Salgueiro; Lucía González Núñez
Journal:  J Nephropharmacol       Date:  2016-01-06

Review 6.  PAI-1 and kidney fibrosis.

Authors:  Li-Jun Ma; Agnes B Fogo
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.